Aster DM Healthcare IPO subscribed 45 percent on day 2

Published On 2018-02-15 04:45 GMT   |   Update On 2018-02-15 04:45 GMT

New Delhi: The initial public offer of Aster DM Healthcare has subscribed 45 percent on the second day of its public issue, according to merchant bankers.


The IPO, which aims to raise Rs 980 crore, received bids for over 1.62 crore shares against the total issue size of over 3.74 crore scrips.


The portion reserved for institutional investors was subscribed 51 percent, non-institutional category 24 percent and retail investors witnessed a subscription of 50 percent, the bankers said.

The company had raised Rs 294 crore from anchor investors on Friday.

Read also: Aster DM Healthcare raises Rs 294 crore from anchor investors

The initial public offer (IPO) comprises the fresh issue of equity shares worth up to Rs 725 crore and an offer for sale of up to 1,34,28,251 scrips by the company's promoter Union Investments.



The price band for the offer, which would be open till February 15, is kept at Rs 180-190 per share.


Read also: Aster DM Healthcare sets IPO price band at Rs 180-190 per share


Proceeds from the issue would be used towards repayment of debt, purchase of medical equipment, and for other general corporate purposes.


Kotak Mahindra Capital Company, Axis Capital and Goldman Sachs (India) Securities, ICICI Securities, JM Financial and Yes Securities will manage the company's public issue.


Aster operates in India, the Philippines, Jordan and all the GCC (Gulf Cooperation Council) states comprising the United Arab Emirates, Oman, Saudi Arabia, Qatar, Kuwait, and Bahrain.
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News